Technical Safety Services, LLC acquires Wisconsin Air Flow, Inc.
Technical Safety Services Authorized by FDA to Decontaminate N95 Respirators
Technical Safety Services (TSS) announced today that the U.S. Food and Drug Administration has issued an emergency use authorization (EUA) using vaporized hydrogen peroxide (HP) to decontaminate compatible N95 respirators in the United States for multiple-user reuse by health care personnel. TSS is ready to decontaminate masks immediately...
Technical Safety Services, LLC acquires Atlantic Technical Systems, Inc.
Technical Safety Services, LLC (TSS) is pleased to announce that it has acquired Atlantic Technical Systems, Inc (ATS), a cleanroom testing and certification services business located in Annapolis, Maryland...
Technical Safety Services, LLC acquires Certification and Testing Services (CTS)
Technical Safety Services, LLC (TSS) is pleased to announce that it has acquired Certification and Testing Services (CTS), a full-service cleanroom and biosafety cabinet certifier for the Medical Device, Pharmaceutical and...
Technical Safety Services, LLC acquires BioTech Balancing
Technical Safety Services, LLC (TSS) is pleased to announce that it has acquired BioTech Balancing (BioTech), an organization that specializes in bridging the gap between HVAC systems and...
Technical Safety Services, LLC acquires LabTech Midwest
Technical Safety Services, LLC (TSS) is pleased to announce that it has acquired LabTech Midwest (LabTech), a service organization providing certifications of biological safety cabinets, chemical fume hoods, laminar flow devices, clean rooms and...
Technical Safety Services, LLC acquires Triangle Certification, LLC
Technical Safety Services, LLC (TSS) is pleased to announce that it has acquired Triangle Certification, LLC, (Triangle) a highly-qualified certified testing and certification...
BioCryst says oral drug works for HAE attacks
BioCryst Pharma says its oral drug BCX7353 was effective in treating acute hereditary angioedema (HAE) attacks in a midstage trial, setting up a possible registration…
EyeGate’s anti-inflammatory eye drug and electric delivery device fail phase 3 trial
EyeGate Pharmaceuticals’ corticosteroid treatment for noninfectious anterior uveitis—delivered directly into the ocular tissue via the company’s device and a low-level…
Radius Health hires oncology-focused CMO as it moves into breast cancer trials
Endocrine therapy developer Radius Health has brought on Charles Morris to be its new chief medical officer and oversee the company’s expansion into oncology…
